Heron Therapeutics
HRTX
#7930
Rank
A$0.39 B
Marketcap
$2.60
Share price
0.00%
Change (1 day)
-27.06%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.86. In 2022 the company made an earnings per share (EPS) of -$2.76 an increase over its 2021 EPS that were of -$3.59.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-36.02%
2022-$2.76-23.11%
2021-$3.59-10%
2020-$3.98-0%
2019-$3.981.21%
2018-$3.94-32.7%
2017-$5.85-19.34%
2016-$7.2554.76%
2015-$4.691.73%
2014-$4.61-16.23%
2013-$5.5091.67%
2012-$2.87-31.45%
2011-$4.18-27.06%
2010-$5.74-43.75%
2009-$10.20-57.33%
2008-$23.90-82.92%
2007-$139.9220.61%
2006-$116.02175.76%
2005-$42.07-21.43%
2004-$53.55100%
2003-$26.77-38.24%
2002-$43.35161.54%
2001-$16.57-106.46%
2000$256.412051.55%
1999$11.92839.73%
1998$1.27-105.48%
1997-$23.16-88.16%
1996-$195.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.07-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.60 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.50-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.63 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA